Intel, Oracle, IBM join growing list of firms objecting to OKX–ICE tokenized stock plans
The latest notice added four objections, bringing the total to 26 as the joint venture prepares to test the SEC’s new framework for blockchain-based stock trading.
Covered in this story
Analyst targets on IBM
- Morgan Stanley: $234 → $238 by Oct 2027 · Equal-Weight via MarketBeat
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 43 stories mentioning IBM, the earliest published 1 Oct 2026.
Summary aggregated from CoinDesk's public RSS feed. The full reporting belongs to CoinDesk — please read it on their site.